Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2 5Phase 3 4Phase 1/2 2Phase 4 1Phase 2/3 1

Status

Completed 7Terminated 1

Sponsor Class

INDUSTRY 5OTHER 2

Study Type

Interventional 7

Sponsor

Cancer Type

Tumor-Agnostic 3Genitourinary 2Other solid neoplasm 1

Conditions

Prostatic Neoplasms 2Neoplasms 2Solid Cancer 1Neoplasm Metastasis 1Advanced Solid Tumor 1

Interventions

Paclitaxel 292Gemcitabine 254Carboplatin 254Cisplatin 251Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 181Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Temozolomide 110Sorafenib 110Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Pemetrexed 90Ipilimumab 90fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 1 × Completed × XRP6258 × Clear all
NCT01420250 2025-05-15

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Thomas Jefferson University

Phase 1 Completed
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT01594918 2017-07-21

Phase I Cabazitaxel, Mitoxantrone, and Prednisone Metastatic Castration-Resistant Prostate Cancer

University of California, San Francisco

Phase 1 Completed
25 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT01140607 2015-07-21

Safety and Pharmacokinetic Study of Cabazitaxel in Patients With Advanced Solid Tumors and Liver Impairment

Sanofi

Phase 1 Completed
56 enrolled
Tumor-Agnostic

Neoplasms

NCT01324583 2015-01-07

Dose Escalation Study With Cabazitaxel in Combination With Daily Prednisolone in Patients With Hormone Refractory Prostate Cancer

Sanofi

Phase 1 Completed
48 enrolled
Genitourinary

Prostatic Neoplasms

NCT00925743 2013-05-16

A Study to Evaluate the Effects of Combining Cabazitaxel With Cisplatin Given Every 3 Weeks in Patients With Advanced Solid Cancer

Sanofi

Phase 1 Completed
76 enrolled

Solid Cancer

NCT01755390 2012-12-24

A Dose Finding Study of XRP6258 in Patients With Advanced Solid Tumors

Sanofi

Phase 1 Completed
42 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT01087021 2011-12-16

QT-Cab

Sanofi

Phase 1 Completed
45 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡